The AGE-RAGE axis in an Arab population: The United Arab Emirates Healthy Futures (UAEHFS) pilot study.

阿拉伯人群的年龄-愤怒轴:阿拉伯联合酋长国健康未来(UAEHFS)试点研究

阅读:9
作者:Inman Claire K, Aljunaibi Abdullah, Koh Hyunwook, Abdulle Abdishakur, Ali Raghib, Alnaeemi Abdullah, Al Zaabi Eiman, Oumeziane Naima, Al Bastaki Marina, Al-Houqani Mohammed, Al-Maskari Fatma, Al Dhaheri Ayesha, Shah Syed M, Abdel Wareth Laila, Al Mahmeed Wael, Alsafar Habiba, Al Anouti Fatme, Al Hosani Ayesha, Haji Muna, Galani Divya, O'Connor Matthew J, Ahn Jiyoung, Kirchhoff Tomas, Sherman Scott, Hayes Richard B, Li Huilin, Ramasamy Ravichandran, Schmidt Ann Marie
AIMS: The transformation of the United Arab Emirates (UAE) from a semi-nomadic to a high income society has been accompanied by increasing rates of obesity and Type 2 diabetes mellitus. We examined if the AGE-RAGE (receptor for advanced glycation endproducts) axis is associated with obesity and diabetes mellitus in the pilot phase of the UAE Healthy Futures Study (UAEHFS). METHODS: 517 Emirati subjects were enrolled and plasma/serum levels of AGE, carboxy methyl lysine (CML)-AGE, soluble (s)RAGE and endogenous secretory (es)RAGE were measured along with weight, height, waist and hip circumference (WC/HC), blood pressure, HbA1c, Vitamin D levels and routine chemistries. The relationship between the AGE-RAGE axis and obesity and diabetes mellitus was tested using proportional odds models and linear regression. RESULTS: After covariate adjustment, AGE levels were significantly associated with diabetes status. Levels of sRAGE and esRAGE were associated with BMI and levels of sRAGE were associated with WC/HC. CONCLUSIONS: The AGE-RAGE axis is associated with diabetes status and obesity in this Arab population. Prospective serial analysis of this axis may identify predictive biomarkers of obesity and cardiometabolic dysfunction in the UAEHFS.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。